Aller au contenu principal
Profil bibliographique

Michael R. Marvin

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

97Publications signalées
2906Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Organ Transplantation Techniques and OutcomesLiver Disease and TransplantationRenal Transplantation Outcomes and TreatmentsHepatocellular Carcinoma Treatment and PrognosisOrgan Donation and Transplantation

Les publications récentes

Accès ouvert 2026 review OpenAlex

Hepatocellular carcinoma metastasis to salivary glands: a systematic review of diagnostic challenges and survival outcomes

Anthony Morada, Caroline Kai Chen, Clifford Akateh, Michael R. Marvin et autres

Background: Hepatocellular carcinoma (HCC) metastasizes predominantly to the lungs, lymph nodes, and bone; salivary gland involvement is exceedingly rare and poorly characterized. We conducted a systematic review to define the clinical profile, diagnostic challenges, and outcomes of this unusual metastatic pattern. Methods: …

us (code pays fourni par la source)

0 citations Journal of Gastrointestinal Oncology
Accès ouvert 2021 article OpenAlex

Region 11 MELD Na exception prospective study

Douglas M. Heuman, James D. Eason, Mark W. Russo, John W. McGillicuddy et autres

"INTRODUCTION: Hyponatremia complicates cirrhosis and predicts short term mortality, including adverse outcomes before and after liver transplantation. MATERIAL AND METHODS: From April 1, 2008, through April 2, 2010, all adult candidates for primary liver transplantation with cirrhosis, listed in Region 11 with …

us (code pays fourni par la source)

0 citations Carolina Digital Repository (University of North Carolina at Chapel Hill)
Accès ouvert 2019 article OpenAlex

Use of rapid Model for End-Stage Liver Disease (MELD) increases for liver transplant registrant prioritization after MELD-Na and Share 35, an evaluation using data from the United Network for Organ Sharing

Guy Brock, Kenneth Washburn, Michael R. Marvin

The Model for End-Stage Liver Disease (MELD) score has been successfully used to prioritize patients on the United States liver transplant waiting list since its adoption in 2002. The United Network for Organ Sharing (UNOS)/Organ Procurement Transplantation Network (OPTN) allocation policy has …

us (code pays fourni par la source)

2 citations PLoS ONE
2017 article OpenAlex

Hemodynamically Directed Two-Person Chest Compressions

Michael Dorbad, Ashley Kass, Michael R. Marvin

Cardiopulmonary resuscitation has a low success rate both in and out of the hospital setting. Return of spontaneous circulation, however, is considerably higher for intraoperative cardiac arrests. Chest compressions remain of utmost importance. Optimal chest compression depth is believed to be greater …

us (code pays fourni par la source)

0 citations A & A Case Reports
Accès ouvert 2017 article OpenAlex

Comparison of two equivalent model for end-stage liver disease scores for hepatocellular carcinoma patients using data from the United Network for Organ Sharing liver transplant waiting list registry

Sarah K. Alver, Douglas Lorenz, Kenneth Washburn, Michael R. Marvin et autres

; P = 0.015, deMELD). While both scores result in better equity of waitlist outcomes compared with scheduled progression, continued development and calibration is recommended.

us (code pays fourni par la source)

10 citations Transplant International
Accès ouvert 2016 article OpenAlex

Projected outcomes of 6‐month delay in exception points versus an equivalent Model for End‐Stage Liver Disease score for hepatocellular carcinoma liver transplant candidates

Sarah K. Alver, Douglas Lorenz, Michael R. Marvin, Guy Brock

The United Network for Organ Sharing (UNOS) recently implemented a 6-month delay before granting exception points to liver transplantation candidates with hepatocellular carcinoma (HCC) to address disparity in transplantation access between HCC and non-HCC patients. An HCC-specific scoring scheme, the Model for …

us (code pays fourni par la source)

29 citations Liver Transplantation
Accès ouvert 2016 article OpenAlex

Minimization of Hypoglycemia as an Adverse Event During Insulin Infusion: Further Refinement of the Yale Protocol

Michael R. Marvin, Silvio E. Inzucchi, Brian Besterman

BACKGROUND: The management of hyperglycemia in the intensive care unit has been a controversial topic for more than a decade, with target ranges varying from 80-110 mg/dL to <200 mg/dL. Multiple insulin infusion protocols exist, including several computerized protocols, which have attempted …

us (code pays fourni par la source)

17 citations Diabetes Technology & Therapeutics
2016 article OpenAlex

Immunobiology in VCA

Christina L. Kaufman, Michael R. Marvin, Paula M. Chilton, James B. Hoying et autres

Transplantation of vascularized composite tissue is a relatively new field that is an amalgamation of experience in solid organ transplantation and reconstructive plastic and orthopedic surgery. What is novel about the immunobiology of VCA is the addition of tissues with unique immunologic …

us (code pays fourni par la source)

44 citations Transplant International
2016 article OpenAlex

Simeprevir and sofosbuvir with or without ribavirin to treat recurrent genotype 1 hepatitis C virus infection after orthotopic liver transplantation

Neil E. Crittenden, Laura Buchanan, Christina Pinkston, Barbra Cave et autres

Although combination simeprevir (SIM) plus sofosbuvir (SOF) is an approved regimen for genotype 1 chronic hepatitis C virus (HCV), data regarding its safety and efficacy in liver transplant recipients remain limited. A multicenter retrospective study was performed to determine the efficacy and …

us (code pays fourni par la source)

21 citations Liver Transplantation

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.